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From photoinduced to dark cytotoxicity via an octahedral cluster 
hydrolysis 
Ekaterina V. Svezhentseva,[a,b] Yuri A. Vorotnikov,[a] Anastasiya O. Solovieva,[c,d] Tatiana N. 
Pozmogova,[b,c] Ilia V. Eltsov,[b] Anton A. Ivanov,[a,d] Darya V. Evtushok,[a] Svetlana M. 
Miroshnichenko,[c,d] Vadim V. Yanshole,[e] Charlotte J. Eling,[f] Ali M. Adawi,[f] Jean-Sebastien G. 
Bouillard,[f] Natalia V. Kuratieva,[a,b] Maria S. Fufaeva,[d] Lidiya V. Shestopalova,[b] Yuri V. Mironov,[a,b] 
Olga A. Efremova,*[f] Michael A. Shestopalov*[a,b,c,d] 
 
Abstract: Octahedral molybdenum and tungsten clusters have the 
potential for biological applications such as photodynamic therapy and 
bioimaging. However, poor solubility and hydrolysis stability of these 
compounds hinder their application. The first water-soluble 
photoluminescent octahedral tungsten cluster [{W6I8}(DMSO)6](NO3)4 
was synthesised and demonstrated to be at least one order of 
magnitude more stable towards hydrolysis than its molybdenum 
analogue. Biological studies of the compound on larynx carcinoma 
cells suggest that it has a significant photoinduced toxicity, while the 
dark toxicity increases with the increase of the degree of hydrolysis. 
The increase of the dark toxicity is associated with the in situ 
generation of nanoparticles that clog up the cisternae of rough 
endoplasmic reticulum. 
Octahedral molybdenum and tungsten clusters of the general 
formula [{M6X8}L6]n (where M = Mo, W, X=Cl, Br or I and L are 
apical organic or inorganic ligands) have become a subject of 
extensive studies after several exceptionally good luminophores 
were discovered among these compounds, in particular those of 
molybdenum.[1] Thanks to intense emission in the red and near-
infrared region of the spectrum and a concomitant ability to 
generate singlet oxygen, these compounds and the materials 
based on them were considered in a range of applications 
including bioimaging,[2] photodynamic therapy,[2b, 2c, 3] 
antibacterial,[4] antiviral,[5] light emitting materials,[6] catalysis[7] 
and many others. 
The majority of synthesised molybdenum clusters described so 
far are only soluble in organic solvents, which significantly hinders 
the examination (let alone utilisation) of the native clusters in 
biomedical research. In this regard, the chemistry of octahedral 
tungsten halide clusters is even less developed, as no water-
soluble/dispersible compounds or materials have been reported 
so far. Indeed, only two water-soluble cluster complexes, 
Na2[Mo6I8(N3)6] and Na2[Mo6I8(NCS)6], were reported.[8] However, 
this work as well as several other works demonstrated that 
molybdenum cluster complexes tend to hydrolyse with partial or 
full substitution of the apical ligands L by H2O or OH−.[3b, 8-9] Here, 
we demonstrate the first photoluminescent water-soluble 
tungsten cluster [{W6I8}(DMSO)6](NO3)4 as well as its 
molybdenum analogue and compare the kinetics of their 
hydrolysis. Specifically, we show that the tungsten compound is 
stable for long enough at physiological temperatures to allow us 
to undertake the first biological studies on any of the tungsten 
clusters and demonstrate not only noticeable photoinduced 
cytotoxicity of the complex but also its ability to generate 
nanoparticles that are taken by the cells and cause dark 
cytotoxicity in the longer term. 
Compounds [{M6I8}(DMSO)6](NO3)4, M = Mo (1) and W (2), were 
obtained directly by heating (Bu4N)2[{M6I8}(NO3)6] in DMSO 
solution at 100 °C in a dry inert atmosphere. (Bu4N)2[{M6I8}(NO3)6] 
(M=Mo, W) are indeed well-recognised precursors for new 
octahedral complexes and materials based on them, due to the 
high lability of nitrato ligands.[1a, 2b-e, 3b, 9-10] Unlike the starting 
compounds, both 1 and 2 were soluble in water. FTIR spectra of 
1 and 2 featured a signal at ~1370 cm–1 that corresponds to ν(N-
O) in uncoordinated NO3–. The signal at ~930-940 cm–1 
corresponds to the S–O stretching frequency in DMSO, but it is 
noticeably red-shifted relative to free DMSO (1005 cm−1), as it 
coordinates to the metal centres via the oxygen atom (ESI Fig. 
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S1).[11] Similar to other octahedral compounds, 1 and 2 
demonstrate luminescence in red/orange region with 
photoluminescence quantum yields of 0.19 and 0.18 in solid state 
at ambient conditions, respectively (ESI Fig. S2-S5, Table S1). 
 
Figure 1. Structure of the cation [{Mo6I8}(DMSO)6]4+ observed in 1·Me2CO. 
Crystals of 1 suitable for single crystal XRD analysis were 
obtained by slow diffusion of acetone vapour into a DMSO 
solution of the complex. According to single crystal XRD, 1 
crystallises as a solvate 1·Me2CO in the trigonal crystal system 
(space group P31c, ESI Table S2). The structure of the cluster 
cation [{Mo6I8}(DMSO)6]4+ is presented in Figure 1, while the unit 
cell packing in Fig S6. The structure of the cluster core {Mo6I8}4+ 
is similar to that found in the starting material and in the related 
compounds,[1a, 1b, 9, 10b, 12] and consists of Mo6 octahedron with 
Mo–Mo distances being equal to 2.6430(5)–2.6591(5) Å with 
triangle faces capped by iodine atoms with Mo–I distances of 
2.7736(4)–2.7836(4) Å. In accordance with FTIR, each Mo atom 
is coordinated via O atoms in DMSO (Mo–O = 2.120(3) Å). 
Unfortunately, we were not successful in growing good quality 
crystals of 2 for single crystal XRD. However, since all known Mo6 
and W6-cluster complexes generally show very similar molecular 
structures[13] and chemical behavior it is reasonable to expect that 
composition of tungsten cluster complex 2 will be the same as the 
molybdenum analogue. Indeed, the nearly identical powder XRD 
patterns of 1 and 2, and good agreement in elemental analysis 
and NMR data clearly confirm that both compounds not only have 
similar molecular structure but also crystallise in the same crystal 
structure. (ESI Fig. S7). 
Although, 1 and 2 were readily soluble in water, some 
precipitation occurred after keeping the aqueous solution thereof 
for several days. These X-ray amorphous precipitates had poor 
luminescence (ESI Fig. S8) and were not soluble in any solvents 
or in water even under heating at different values of pH. The W:S 
ratio of 6:0.23 determined by EDX as well as FTIR (ESI Fig. S9) 
suggested that the replacement of DMSO ligand took place, likely 
due to hydrolysis. Indeed, the formation of poorly soluble aqua-
hydroxo complexes [{M6I8}(H2O)2(OH)4]∙xH2O upon hydrolysis is 
well documented.[10a, 13a, 14] 
Mass spectroscopy (ESI-MS) experiments of 1 and 2 in fresh 
aqueous solution, in fresh 1% DMSO solution and in aqueous 
solution aged for four days (Fig. 2, ESI Fig. S10-S13) detected 
the whole family of chemical forms and associates with general 
formula [{M6I8}(DMSO)6-x(H2O)z(OH)y(NO3)k-y]4–k (M = Mo, W, x = 
0-6, z = 0-10, y = 0-3, k = 0-3). The composition of the chemical 
forms in the solutions depended on the age of the solution, i.e. the 
degree of hydrolysis increased after 4 days. The hydrolysis was, 
however, noticeably slower for the tungsten compound, as unlike 
1, there was still a significant amount of the chemical forms 
containing up to 5 DMSO ligands in the aqueous solution of 2 after 
4 days (ESI Fig. S13). Notably, in both cases the presence of 1% 
DMSO in the fresh aqueous solution significantly increased the 
amount of DMSO-containing forms (ESI Fig. S10 and 12), which 
suggests that the hydrolysis is to some extent reversible. Such a 
significant discrepancy in the reaction kinetics on Mo and W metal 
centres in complexes was mentioned in literature.[15] 
The detailed kinetic studies of hydrolysis of 1 and 2 were 
undertaken in pseudo-first order conditions in saturated D2O 
solution using 1H NMR (ESI Fig. S14-S19) at temperatures of 300, 
320 and 340 K. The pre-exponential kinetic factor (k0) and 
activation energy (Ea) as well as entropy (S) and the enthalpy 
(H) of transition states, were determined according to Arrhenius 
and Eyring equations, respectively (ESI Fig. S20-S21, Table S9). 
Our data demonstrate that the hydrolysis of 1 at each temperature 
point is approximately one order of magnitude faster than 2, which 
agrees well with ESI-MS data. The activation energy, as well as 
the transition state enthalpy for hydrolysis of 2 is higher than that 
of 1 by about 27 kJ/mol. This difference may signify Mo-DMSO 
bond being somewhat weaker than W-DMSO, which explains the 
higher stability of 2. The estimated value of transition state 
entropy of 1, –44 ± 3 kJ mol−1, suggests that it hydrolyses via the 
associative mechanism. In regards to 2, the proximity of the 
entropy value to 0 suggests that both associative and dissociative 
mechanisms take place, probably, at the different stages of 
hydrolysis. 
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Figure 2. ESI-MS spectra (black) of the fresh aqueous solution of 1 (A) or 2 (B) 
and a simulation of some cluster forms (coloured) 
 
Figure 3. Dark and photoinduced cytotoxicity of 2 for Hep-2 cells. A) Cytotoxicity of fresh aqueous solutions against incubation time; B) Cytotoxicity of 4-days old 
aqueous solutions versus incubation time; C) Cytotoxicity of fresh, 4- and 7-days old solutions after incubation for 48 hours, D) Photoinduced toxicity of fresh and 
aged solutions after light irradiation (a total light dose 20 J/cm2). Error bars represent the standard error of the mean cell viability for at least 3 replicate measurements. 
Although for many applications of metal complexes, hydrolysis is 
detrimental, it should be noted that for antitumor activity of a 
majority of transition metal-based drugs, such as cisplatin, 
RAPTA and alike, hydrolysis is an important step in the mode of 
their actions. Moreover, it is often important that hydrolysis is not 
too fast to allow the drug molecules to internalise into cells 
efficiently and bind to DNA but not so slow that the hydrolysis 
happens before the drug elimination.[16] From the kinetic data we 
estimated the half-life time in aqueous solutions under 
physiological temperature (37 °C) of 1 is equal to only 52 min, 
which is too short for biological applications, while it is 34 h for 2, 
i.e. longer than the typical cellular uptake times. Therefore, we 
were interested to evaluate whether hydrolysis has any effect on 
both dark and light-induced cytotoxicity of this compound. 
All cytotoxicity studies were undertaken on human larynx 
carcinoma cells (Hep-2) using MTT assay. For the dark 
cytotoxicity studies, the cells were incubated for 6, 24 or 48 h with 
either freshly prepared solution of 2 or the solutions aged at room 
temperature for several days (Fig. 3A-C). The assays on the fresh 
solution of 2 showed that its cytotoxicity gradually increased with 
the increase of time of incubation. However, the half-maximal 
inhibitory concentration (IC50) value was still not achieved within 
the studied concentration range (i.e. IC50>1.06 mM). Notably, 
aged solutions had a significantly higher cytotoxic effect with IC50 
values of 0.85±0.07 mM (for 4-day old solution) and 0.24±0.01 
mM (for 7-day old solution) after 48 h of incubation. These data 
demonstrate that hydrolysed forms have higher dark cellular 
toxicity in comparison with the starting DMSO complexes. For 
comparison, IC50 values for the only known water-soluble 
molybdenum clusters, namely Na2[{Mo6I8}(NCS)6] and 
Na2[{Mo6I8}(N3)6], studied in vitro HeLa and HEK 293T cells, were 
about one order of magnitude smaller. Notably, the toxicity of 
Na2[{Mo6I8}(NCS)6] demonstrated a similar pattern as 2, i.e. the 
toxicity of the solution increased with the incubation time: IC50 for 
HeLa was 33 to 48 and 18 µM cells after 24, 48 and 72 h, 
respectively. The higher long-term toxicity of  Na2[{Mo6I8}(NCS)6] 
might also be associated with the increased toxicity of the partially 
hydrolysed species [{Mo6I8}(NCS)5(OH)]2, which the article 
authors have detected.[8] 
Earlier, we demonstrated that silica nanoparticles doped by 
octahedral molybdenum cluster complexes exhibit significant 
photoinduced toxicity.[2b] Moreover, the vast range of theoretical 
and experimental studies convincingly demonstrate that 
molybdenum clusters are capable of singlet oxygen generation.[1b, 
2b, 2c, 3b, 4, 8, 10a, 12a, 17] Tungsten cluster complexes are far less 
studied in this regard. Hence we also undertook photoinduced 
toxicity studies. The viability test was performed after 4 h 
incubation of the cells with either freshly prepared or aged for 4 
days solutions of 2 within the safe concentration range followed 
by an irradiation of the cells with the light (λ ≥ 400 nm) for 30 min. 
Our data demonstrate that at the highest tested concentration 
(132 μM), the fresh solution of 2 is more phototoxic than that of 
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the aged solution: 28±4 % of cells survived with the fresh solution 
vs. 62±2% with the aged solution (Fig. 3D). This demonstrates the 
higher photodynamic activity of 2 in comparison with its 
hydrolysed forms.  
To establish whether the photoinduced toxicity is caused by 
reactive oxygen species (ROS) (including singlet oxygen), we 
determined the level of intracellular ROS within Hep-2 cells by 
using cell-permeable fluorescent probe 5,6-carboxy-2′,7′-
dichlorofluoresceindiacetate (DCFH-DA). Specifically, the cells 
were first incubated with 2 followed by incubation with DCFH-DA 
and then the fluorescence level of the cells (indicative of ROS 
concentration) was measured using IN Cell Analyzer. The cells 
incubated with either a cluster-free media or with H2O2 (i.e. 
irradiation-independent ROS source) were used as a negative 
and a positive control, respectively. Our data (Fig S22-F23) 
demonstrate that the levels of ROS in the positive and in the 
negative control experiments were invariant to irradiation, 
whereas the level of ROS in the presence of both fresh and 4-day 
old solutions of 2 was significantly higher after photoirradiation. 
Notably, the level of ROS in the cells treated by 2 without 
photoirradiation was the same as for the negative control meaning 
that intracellular ROS were generated by 2 solely upon 
photoirradiation. Moreover, the level of ROS in the cells incubated 
with the fresh solution of 2 was about 50% higher than that for the 
aged solution, which follows the same trend as the photoinduced 
toxicity data above. Although, the DCFH-DA probe does not 
differentiate between singlet oxygen and other ROS, similarity in 
the optical properties of molybdenum and tungsten clusters [17b, 18] 
suggests that the photoinduced toxicity of 2 is likely to be due to 
the singlet oxygen generation. Although detailed spectroscopic 
studies are still required to establish details of photosensitisation 
mechanism of 2. 
To understand, why hydrolysis of the cluster increases its dark 
cellular toxicity, we have studied internalisation of 2 in Hep-2 cells 
in more detail. Flow cytometry (FACS) analysis of the cells after  
 
Figure 4. Percentage of fluorescence positive cells after incubation with fresh 
solution and 4-days old solution of 2 for 0.25 and 4 hours (A). Fluorescent 
microscopic images (B, C and D) of Hep-2 cells incubated with 2, where yellow 
is cytoskeleton stained by Phalloidin, blue is nucleus stained by Hoechst33342 
and red is emission from 2. 
15 min and 4 h of incubation with the freshly prepared and aged 
for 4 days solutions at non-toxic concentration demonstrate that 
the cluster from the aged solution is taken up by the cells better 
than from the fresh solution (Fig. 4A and S24). Indeed, despite 
the fact that hydrolysis of 2 leads to significant decrease of 
luminescence intensity of metal cluster[13a], the cells incubated 
with the aged solution were noticeably more emissive already 
after 15 minutes than those incubated with the freshly prepared 
solutions. 
Confocal laser scanning microscope (CLSM) imaging of the cells 
incubated with the 4-day-aged solution of 2 (0.132 mM) for 24 h 
demonstrated bright red emission localised in the perinuclear 
space (Fig. 4B-D). TEM imaging provided even more detailed 
information about localisation and the chemical form of the 
clusters within the cells. Namely, it demonstrated that the clusters 
within a cell were in the form of nanoparticles of various sizes < 
40 nm (Fig. 5). For comparison, the size of one cluster with the 
ligands is no more than 1 nm. The dynamic light scattering of the 
studied solution, indeed, confirmed the presence of nanoparticles 
with the average size of 20 nm (ESI Fig. S25), which are likely 
agglomerates of fully and/or partially hydrolysed species held 
together by strong intermolecular hydrogen bonding. Indeed, the 
emission profile of the nanoparticles separated from solution (Fig. 
S4) is similar to the literature data for [{W6I8}(H2O)2(OH)4]∙6H2O. 
According to the FACS data (Fig. 4A) the presence of the 
nanoparticles in the cells with concomitant higher intensity of 
luminescence from the cells suggests that the particles are taken 
up more easily than the non-hydrolysed complex 2, possibly due 
to the difference in the mechanism of uptake between 
nanoparticles and molecular complexes. Moreover, Fig. 5 also 
shows that the nanoparticles are located within single membrane 
vesicles as well as in the cisternae of endoplasmic reticulum (ER). 
 
Figure 5. TEM images of ultrathin sections of Hep-2 cells: (A) control cells; (B-
C) are the cells incubated with 2. Selected region of cytoplasm with single-
membrane vesicles containing nanoparticles generated from 2 is shown at 
greater scale in panel. Arrows on (B) point to the ER’s cisterns. 
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The overload of ER (the organelle responsible for the 
accumulation of exogenous and endogenous molecules and ions 
among other functions) with the nanoparticles might lead to the 
expansion of ER followed by the cell death. Indeed, it is generally 
agreed that exposure of cells to nanoparticles can induce cellular 
toxicity via ER stress (i.e. accumulation of the misfolded proteins 
in the ER),[19] upon which the size of the ER can expand to 
increase protein folding capacity.[20] Moreover, in several studies 
it was also shown that cancerous cells may be particularly prone 
to apoptosis mediated by ER stress.[21] On the other hand the 
close proximity of the cluster to the cellular nucleus facilitates the 
photodynamic toxicity demonstrated above. 
There are several major conclusions that can be drawn from this 
work. Firstly, using [{W6I8}(DMSO)6](NO3)4 as an example, it is 
demonstrated that photoluminescent cluster complexes may have 
an advantage over similar molybdenum compounds for 
biomedical applications due to significantly increased stability of 
the latter towards hydrolysis. Secondly, upon hydrolysis 
octahedral clusters initially assemble into nanoparticles that retain 
some photoluminescent properties. This unexpected feature will 
require further investigation into how the properties and sizes of 
the particles can be controlled and whether they can be 
functionalised. This is particularly important in the context of the 
third conclusion – the cellular uptake of the metal cluster-based 
nanoparticles was more efficient than that of the molecular 
complex, probably due to the differences in the uptake 
mechanisms between complexes and nanoparticles. Finally, 
although IC50 values for 2 were about an order of magnitude 
higher than the state-of-the-art anti-cancerous drugs, the concept 
of a drug that initially is luminescent (and thus can be employed 
as an imaging and/or PDT agent), but consequently is capable to 
convert into a cytostatic moiety could be an interesting and novel 
approach to the development of theranostic and/or multimodal 
therapeutic agents. In this respect octahedral cluster complexes 
may be of particular interest due to their photoluminescence 
combined with the ability to hydrolyse and to bind strongly to a 
range of donor groups.[16b-d] 
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